Skip to content

Efficacy and Safety of Cold Versus Hot Snare Polypectomy for Removal of 4-10 mm Pedunculated Colorectal Polyps

Efficacy and Safety of Cold Versus Hot Snare Polypectomy for Removal of 4-10 mm Pedunculated Colorectal Polyps: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06937047
Enrollment
196
Registered
2025-04-20
Start date
2025-05-06
Completion date
2027-02-28
Last updated
2025-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Polyps

Brief summary

This was a non-inferiority randomized controlled trial designed to compare the efficacy and safety of cold versus hot snare polypectomy for the removal of 4-10 mm pedunculated colorectal polyps. The primary outcome was delayed postpolypectomy bleeding. The secondary outcomes included immediate postpolypectomy bleeding, procedure time, en bloc resection, complete histologic resection, use of haemostatic clips and perforation rate.

Interventions

Cold snare polypectomy was conducted for the removal of 4-10 mm pedunculated colorectal polyps.

Hot snare polypectomy was conducted for the removal of 4-10 mm pedunculated colorectal polyps.

Sponsors

Shandong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. 18-80 years old, male and female 2. Proposed colonoscopy and colonoscopy detection of at least one 4-10 mm pedunculated colorectal polyp

Exclusion criteria

1. Contraindication to colonoscopy or polypectomy 2. Use of antiplatelet or anticoagulant drugs within 1 week before polypectomy 3. Alarming signs and symptoms of colorectal cancer (blood in stool, black stool, unexplained anaemia and weight loss, abdominal mass, positive rectal examination; or imaging and laboratory tests highly suspicious for colorectal cancer) or endoscopic manifestations of polyps highly suspicious for high-grade intraepithelial neoplasia or carcinoma 4. Comorbidity with inflammatory bowel disease, colonic polyposis, or active gastrointestinal bleeding 5. Inadequate bowel preparation 6. Pregnant or lactating women 7. Failure to sign the informed consent form 8. Patients deemed ineligible by investigators to enrol in the trial

Design outcomes

Primary

MeasureTime frameDescription
delayed postoperative bleedinginterviewed by telephone on days 2 and 14 after polypectomybleeding that developed within 2 weeks after the patient left the endoscopy unit

Secondary

MeasureTime frameDescription
immediate postpolypectomy bleedingduring the polypectomyBlood spray or persistent oozing for more than 60 seconds requiring endoscopic intervention
procedure timeduring the polypectomyThe duration from the appearance of the snare on the monitor to the time when the endoscope was withdrawn from the lesion
perforation rateduring the polypectomy, and interviewed by telephone on days 2 and 14 after polypectomyProportion of patients with intraoperative or postoperative perforation
complete histologic resectionduring the polypectomyClear resection margins, no polyp involvement
use of haemostatic clipsduring the polypectomy
en bloc resectionduring the polypectomyRemoval of a polyp with a single cut and was assessed by the colonoscopist

Countries

China

Contacts

Primary ContactYanqing Li
liyanqing@sdu.edu.cn+8653182169508

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026